Survey of Ophthalmology
Volume 49, Issue 1 , Pages 78-89, January 2004

Ocular tuberculosis masquerading as ocular tumors

1Oncology Service, Wills Eye Hospital, Thomas Jefferson University, and 2Pathology Department, Wills Eye Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania, USA

Abstract 

Tuberculosis has re-emerged as a serious public health problem in recent years. The ocular manifestations of tuberculosis are uncommon and diverse. Occasionally, patients initially present with ocular symptoms that simulate intraocular malignancy or other inflammatory conditions. We present five patients with ocular tuberculosis who were referred with the suspicion of ocular malignancy. Four of the five patients had recently emigrated to the United States. The presenting features of these patients were panophthalmitis (one patient), endophthalmitis leading to scleral perforation (one patient), active choroidal granuloma associated with uveitis (two patients), and amelanotic choroidal lesion without inflammatory signs (one patient). Of these five cases, two had a known history of systemic tuberculosis, while the ocular findings in the other three cases were the presenting manifestation of systemic tuberculosis. Multi-drug antituberculous regimen were employed in all cases for a mean of 9 months (median 6 months, range 6–12 months). Three patients responded well to therapy with salvage of the globe and the two remaining patients underwent primary enucleation for blind painful eye or perforated eye. In conclusion, ocular tuberculosis can have variable clinical manifestations and occasionally appears as an intraocular or epibulbar tumor. A high degree of clinical suspicion is important, especially in immigrants from developing countries.

Keywords:  choroid, eye, granuloma, inflammation, melanoma, retina, tuberculosis, tumor, uvea, uveitis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Support provided by the Paul Kayser International Award of Merit in Retina Research, Houston, TX (J. Shields), Macula Foundation, New York, NY (C. Shields), the Noel T. and Sara L. Simmonds Endowment for Ophthalmic Pathology, Wills Eye Hospital (R. Eagle, Jr) and the Eye Tumor Research Foundation, Philadelphia, PA (C. Shields). The patients were referred to the authors by Brian C. Leonard, MD, John Lehr, MD, Richard Klein, MD, James Bastek, MD, Jay Biswas, MD. The authors reported no proprietary or commercial interest in any product mentioned or concept discussed in this article.

PII: S0039-6257(03)00131-0

doi:10.1016/j.survophthal.2003.10.009

Survey of Ophthalmology
Volume 49, Issue 1 , Pages 78-89, January 2004